Estimates Revisions Cutia Therapeutics

Stocks

Market Closed - Hong Kong S.E. Other stock markets 04:08:08 2026-06-18 EDT			5-day change	1st Jan Change
3.200 ^HKD	+3.90%		-1.23%	-29.52%

05-07	Cutia Therapeutics Announces Drug Marketing Authorization for CU-30101 Localized Topical Lidocaine and Tetracaine Cream	CI
05-06	Cutia Therapeutics' Topical Anesthetic CU-30101 Approved in China	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	CUTIA THERAPEUTICS
	ELI LILLY AND COMPANY
	JOHNSON & JOHNSON
	ABBVIE INC.
	ROCHE HOLDING AG
	ASTRAZENECA PLC
	NOVARTIS AG
	NOVO NORDISK A/S
	AMGEN INC.
	GILEAD SCIENCES, INC.
	Average
	Weighted average by Cap.